Katrina M. Nolan

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults

Helen Stacey, Jeffrey B. Rosen, James T. Peterson et al. · Human Vaccines & Immunotherapeutics · 2019 · 111 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

V3 Loop Truncations in HIV-1 Envelope Impart Resistance to Coreceptor Inhibitors and Enhanced Sensitivity to Neutralizing Antibodies

Meg M. Laakso, Fang-Hua Lee, Beth Haggarty et al. · PLoS Pathogens · 2007 · 75 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +13

A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

Heather Platt, David Greenberg, Bruce Tapiéro et al. · The Pediatric Infectious Disease Journal · 2020 · 64 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

A dose ranging study of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants

Randall G. Rupp, David Hurley, Staci Grayson et al. · Human Vaccines & Immunotherapeutics · 2019 · 60 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmaceutics +17

Enhanced Antipneumococcal Antibody Electrochemiluminescence Assay: Validation and Bridging to the WHO Reference ELISA

Katrina M. Nolan, Yuhua Zhang, Joseph M. Antonello et al. · Bioanalysis · 2020 · 47 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17